Top Story

Kelman lecturer works toward new treatment for corneal endothelial dysfunction

Kelman lecturer works toward new treatment for corneal endothelial dysfunction
April 21, 2015

SAN DIEGO — Shigeru Kinoshita, MD, PhD, detailed the clinical application of cultivated cells and the medical treatment for corneal endothelial dysfunction during the Charles D. Kelman Innovator’s Lecture here.

“We now have PKP, DSEK or DMEK, but in addition to that, we may be able to add additional treatments such as the cell injection of the cultivated corneal endothelial cells or the Rho-kinase inhibitor and eye drops,” he said at the American Society of Cataract and Refractive Surgery annual meeting.

High spectacle independence, patient satisfaction seen with At Lisa trifocal toric IOL Meeting News Coverage

High spectacle independence, patient satisfaction seen with At Lisa trifocal toric IOL

April 21, 2015
SAN DIEGO — A trifocal toric IOL may result in a high degree of spectacle independence and patient satisfaction, according to a presentation here.At the American…
The Dry EyePublication Exclusive

The Hill of Sorrow: Understanding the symptom curve in the treatment of dry eye

Ocular Surgery News U.S. Edition, April 25, 2015
Darrell E. White, MD
“No pain, no gain” is a lousy philosophy in physical fitness, and it is particularly difficult to sell it in any medical setting. Yet this is exactly what we must do…
LASIK still a valuable investment 20 years after surgery Refractive Surgery StoriesPublication Exclusive

LASIK still a valuable investment 20 years after surgery

Ocular Surgery News U.S. Edition, April 25, 2015
Manuel J. Chaknis, MD
We refractive surgeons often encounter patients who, in consultation, bring up concerns that LASIK “wears off.” Manuel J. Chaknis had his LASIK procedure almost 20 years…
Seenu M. Hariprasad, MD Cover StoryPublication Exclusive

Protocol T comparison of anti-VEGFs gives clinicians guidance for treating DME

Ocular Surgery News U.S. Edition, April 25, 2015
Eagerly awaited findings of the DRCR.net Protocol T study did not disappoint, delivering “exciting” results for retina specialists looking for an answer to the question…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Managing Glaucoma 24/7

Managing Glaucoma 24/7: New Insights About Old Dilemmas

This activity is supported by an educational grant from Alcon Research, LTD.

Intraocular pressure (IOP) control is a vital component in the management of glaucoma. In recent years, it has become…
More »
Meeting News Coverage Video
VIDEO: Vice president gives company business update

VIDEO: Vice president gives company business update

April 21, 2015
SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting here, Robert Dempsey, vice president…
More »